- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Pharmacokinetics of Human Factor IX in a dog with Severe Hemophilia B. ; volume:38 ; number:02 ; year:1977
Konferenz: VIth International Congress on Thrombosis and Haemostasis; 1977-06-27
Thrombosis and haemostasis ; 38, Heft 02 (1977)
- Contributor
-
Gentry, P.A.
Thompson, A.R.
Forrey, A.W.
- DOI
-
10.1055/s-0039-1682760
- URN
-
urn:nbn:de:101:1-2019061208121369818370
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gentry, P.A.
- Thompson, A.R.
- Forrey, A.W.
Other Objects (12)
Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
Femoral Fractures in Severe Hemophilia
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Factor VIII (FVIII) Antibodies in Hemophilia
Emicizumab for All Pediatric Patients with Severe Hemophilia A
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
Aortic Valve Replacement in a Patient with Severe Hemophilia B.
Inhibitors in Severe Hemophilia A: 25-Year Experience in Slovakia
Leukemia in Families with Isolated Cases of Severe Hemophilia A.
Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
Femoral Fractures in Severe Hemophilia
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Factor VIII (FVIII) Antibodies in Hemophilia
Emicizumab for All Pediatric Patients with Severe Hemophilia A
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
Aortic Valve Replacement in a Patient with Severe Hemophilia B.
Inhibitors in Severe Hemophilia A: 25-Year Experience in Slovakia
Leukemia in Families with Isolated Cases of Severe Hemophilia A.
Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
Femoral Fractures in Severe Hemophilia
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
Factor VIII (FVIII) Antibodies in Hemophilia
Emicizumab for All Pediatric Patients with Severe Hemophilia A
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
Aortic Valve Replacement in a Patient with Severe Hemophilia B.
Inhibitors in Severe Hemophilia A: 25-Year Experience in Slovakia